The current meta-analysis also showed a significant increase in IOP after DEX implants compared to anti-VEGF treatment, which agreed with another meta-analysis that compared DEX implants and anti-VEGF treatment related to diabetic retinopathy [36]. The gene discussed is VEGFA; the disease is diabetic retinopathy.